Dr Niels Pallisgaard | Molecular Biologist
Zealand University Hospital | Denmark

Dr Niels Pallisgaard, Molecular Biologist, Zealand University Hospital

Niels Pallisgaard has worked more than 20 years with clinical molecular Hematology. He has contributed internationally to the standardization of qPCR MRD monitoring of leukemia by chairing the Europe Against Cancer (EAC) reference gene workgroup, by chairing the MPN-EuroNet workgroup on quantitative JAK2, CALR and MPL standardization and as a member of the EUTOS (EUropean Treatment and Outcome Study) workgroup focusing on new technologies in the management of patients with CML. He has for nearly 10 years been pioneering work on cfDNA and ctDNA in liquid biopsies using qPCR and digital droplet PCR (ddPCR).

Appearances:



Oct 28th Pre-Congress Workshops @ 14:00

Workshop D: Improvement of cancer patient treatment outcomes: Using liquid biopsies & novel biomarkers for predicting prognosis and response

Join this workshop to learn about new and emerging biomarkers, and discuss how to overcome the limitations of liquid biopsiesBiomarker Strategy
  • Using a proteomic approach to identify new biomarkers for risk detection and response to therapy
  • Developing and implementing biomarker strategies into early clinical trial designs
  • Emerging Biomarkers: Microbiome
  • Liquid biopsy for what purpose? Relapse? Prediction purposes?
  • -Insight into use of liquid biopsy in solid tumours
  • Application of liquid biopsies in haematological malignancies
  • Circulating cancer biomarkers, what can we do?
last published: 16/Sep/19 14:05 GMT

back to speakers

Sign Up for Event Updates